{"ticker": {"uuid": "60097d4c-b0ae-44e9-8ac9-0884dd97ec88", "symbol": "688366", "name": "Shanghai Haohai Biological Technology Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to book forward of Shanghai Haohai Biological Technology Co., Ltd. Class A \u2013 SSE:688366", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTzVXWlBZa1Z6Zlg5NzBwWTd0QlBYcEVhSXB1UTJPNnBCV1k0TlpvQi1YS0lSQkJtMFg5LUdaa2RlTmh2RHBBQTllbFliQVZQWExsQmFsQ2F2SmtnOFJ1dnJUQWNBUm8tVDVOWHlKd29oRmp4Q0diQmE2MDA4VVJnNHBLVUk2WVVSMXRQeHoySk9qc1g5alZPUkRUNA?oc=5", "source_name": "TradingView", "published_at": "2026-06-27T06:11:05+00:00", "published_display": "27 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxNbnpRSy1tekF2bVE5bnVSSUlZLUVjMWd6WWk5ellEUDBWZmxCRDFrc19JSTh1TVRNdWZPU0ZiX0pWWGo1OVFTRXdES0YwdDNMOGR5ZXkwMGhObHFPSlViVDl3TjZnS1ZRN1VKMktLVXF0VmhyRnRneWd1TVdPQVZUMmdIbFYxcE1FZWlESVZ5QWU1NmdFYjVJQ2syVWc0Z1JBY0pBbjFyUGdQMlhuLVBFVnhJMkdyUW1hVEtPZ0d1RE1LOXZ1RGQ2Tk1zeTA1ZmU5Zmt2ZTQ5M05FSVFPYnh5N2dXOW16VERjTlo2ZHI1a3d6Sy1vbzFkU2pESUl5emdicGo0ai1qTVFyWGJ3a2RZTw?oc=5", "source_name": "PR Newswire", "published_at": "2021-03-09T08:00:00+00:00", "published_display": "09 Mar 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to book forward of Shanghai Haohai Biological Technology Co., Ltd. Class A \u2013 SSE:688366", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTzVXWlBZa1Z6Zlg5NzBwWTd0QlBYcEVhSXB1UTJPNnBCV1k0TlpvQi1YS0lSQkJtMFg5LUdaa2RlTmh2RHBBQTllbFliQVZQWExsQmFsQ2F2SmtnOFJ1dnJUQWNBUm8tVDVOWHlKd29oRmp4Q0diQmE2MDA4VVJnNHBLVUk2WVVSMXRQeHoySk9qc1g5alZPUkRUNA?oc=5", "source_name": "TradingView", "published_at": "2026-06-27T06:11:05+00:00", "published_display": "27 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxNbnpRSy1tekF2bVE5bnVSSUlZLUVjMWd6WWk5ellEUDBWZmxCRDFrc19JSTh1TVRNdWZPU0ZiX0pWWGo1OVFTRXdES0YwdDNMOGR5ZXkwMGhObHFPSlViVDl3TjZnS1ZRN1VKMktLVXF0VmhyRnRneWd1TVdPQVZUMmdIbFYxcE1FZWlESVZ5QWU1NmdFYjVJQ2syVWc0Z1JBY0pBbjFyUGdQMlhuLVBFVnhJMkdyUW1hVEtPZ0d1RE1LOXZ1RGQ2Tk1zeTA1ZmU5Zmt2ZTQ5M05FSVFPYnh5N2dXOW16VERjTlo2ZHI1a3d6Sy1vbzFkU2pESUl5emdicGo0ai1qTVFyWGJ3a2RZTw?oc=5", "source_name": "PR Newswire", "published_at": "2021-03-09T08:00:00+00:00", "published_display": "09 Mar 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 57, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 58, "events": [{"event": "general", "label": "Market update", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 31.98, "latest_week": "2026-07-17", "one_week_move": 3.3, "four_week_move": 6.1, "twelve_week_move": -17.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.873195, "market_dynamics_buy_signal": false, "relative_strength": -25.107604, "fair_value_gap": -43.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.6675, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.3% over one week, +6.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 1}, {"label": "PR Newswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.3% over one week, +6.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to book forward of Shanghai Haohai Biological Technology Co., Ltd. Class A \u2013 SSE:688366"}], "updated_at": "2026-07-21T20:59:37.100605+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}